Biperiden hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for biperiden hydrochloride and what is the scope of patent protection?
Biperiden hydrochloride
is the generic ingredient in one branded drug marketed by Abbvie and is included in one NDA. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for biperiden hydrochloride.
Summary for biperiden hydrochloride
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 58 |
| Clinical Trials: | 10 |
| Patent Applications: | 388 |
| DailyMed Link: | biperiden hydrochloride at DailyMed |
Recent Clinical Trials for biperiden hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ministry of Health, Brazil | Phase 3 |
| Hospital Sirio-Libanes | Phase 3 |
| PROADI-SUS | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for biperiden hydrochloride
US Patents and Regulatory Information for biperiden hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | AKINETON | biperiden hydrochloride | TABLET;ORAL | 012003-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
